A multicenter prospective observational study on the safety and efficacy of tacrolimus in patients with myasthenia gravis
Suk-Won Ahn(Chung-Ang University Hospital), Young Eun Park(Yonsei University), Eun Bin Cho(Changwon National University), Jung‐Joon Sung(Seoul National University), Ha Young Shin(Yonsei University), Tai‐Seung Nam(Chonnam National University Hospital), Byung‐Jo Kim(Korea University), Sa‐Yoon Kang(Jeju National University), In Soo Joo(Ajou University), Yang‐Ki Minn(Hallym University), Jung Im Seok(Soonchunhyang University), Yoon‐Ho Hong(Seoul Metropolitan Government), Jeeyoung Oh(Université Paris-Sud), Hung Youl Seok(Keimyung University), Jin‐Sung Park(Kyungpook National University Hospital), Sun‐Young Oh(Inje University Busan Paik Hospital), Ju‐Hong Min(Samsung Medical Center), Jin-Myoung Seok(Soonchunhyang University), Je-Young Shin(Seoul National University Hospital), Bum Chun Suh(Kangbuk Samsung Hospital), Byoung-Joon Kim(Samsung Medical Center)
Cited by 11
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
A New Subtype Classification of Ischemic Stroke Based on Treatment and Etiologic Mechanism
|European Neurology|2006|121
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82